Halozyme Therapeutics Inc. logo

Halozyme Therapeutics Inc. (0J2O)

Market Closed
3 Jun, 15:30
LSE LSE
$
69. 88
+3.59
+5.42%
$
- Market Cap
20.87 P/E Ratio
- Div Yield
474 Volume
2.74 Eps
$ 66.29
Previous Close
Add Transaction
Day Range
65.74 70.06
Year Range
51.08 84.23
Want to track 0J2O and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Halozyme Therapeutics Inc. logo
0J2O Halozyme Therapeutics Inc.
5 May 2026
1.52
-
Halozyme Therapeutics Inc. logo
0J2O Halozyme Therapeutics Inc.
17 Feb 2026
2.2
-
Halozyme Therapeutics Inc. logo
0J2O Halozyme Therapeutics Inc.
29 Oct 2025
-
-
Halozyme Therapeutics Inc. logo
0J2O Halozyme Therapeutics Inc.
4 Aug 2025
-
-

0J2O Earnings Reports FAQ

What is the earnings per share (EPS) for 0J2O?

The current EPS is 2.74.

What is the company's earnings growth rate?

Halozyme Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Halozyme Therapeutics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Halozyme Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 0J2O at this time, as Halozyme Therapeutics Inc has no recent EPS data to calculate it.